{"id":"https://openalex.org/W1571370939","doi":null,"title":"Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapy.","display_name":"Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapy.","publication_year":1993,"publication_date":"1993-12-01","ids":{"openalex":"https://openalex.org/W1571370939","mag":"1571370939","pmid":"https://pubmed.ncbi.nlm.nih.gov/8242624"},"language":"en","primary_location":{"id":"pmid:8242624","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8242624","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113527586","display_name":"Richard Paul Junghans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R P Junghans","raw_affiliation_strings":["Division of Hematology-Oncology, Harvard Medical School, New England Deaconess Hospital, Boston, Massachusetts 02215"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Harvard Medical School, New England Deaconess Hospital, Boston, Massachusetts 02215","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D Dobbs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Dobbs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108441025","display_name":"M W Brechbiel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M W Brechbiel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045360887","display_name":"Saed Mirzadeh","orcid":"https://orcid.org/0000-0002-1774-7958","observed_orcids":["https://orcid.org/0000-0002-1774-7958"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Mirzadeh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072320451","display_name":"Andrew Antony Raubitschek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A A Raubitschek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109892031","display_name":"Otto A. Gansow","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O A Gansow","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111859562","display_name":"Thomas A. Waldmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T A Waldmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.9579,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":{"value":0.94569931,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"53","issue":"23","first_page":"5683","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13561","display_name":"Chemical Reactions and Isotopes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bismuth-212","display_name":"bismuth-212","score":0.9559999704360962},{"id":"https://openalex.org/keywords/anti-tac-monoclonal-antibody","display_name":"anti-Tac monoclonal antibody","score":0.9559999704360962},{"id":"https://openalex.org/keywords/il-2-receptor","display_name":"interleukin-2 receptor","score":0.9020000100135803},{"id":"https://openalex.org/keywords/antibody-pharmacokinetics","display_name":"antibody pharmacokinetics","score":0.7229999899864197},{"id":"https://openalex.org/keywords/antibody-stability","display_name":"antibody stability","score":0.5879999995231628},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.671999990940094},{"id":"https://openalex.org/keywords/reticuloendothelial-system","display_name":"reticuloendothelial system","score":0.7450000047683716},{"id":"https://openalex.org/keywords/radioiodine","display_name":"radioactive iodine","score":0.5450000166893005}],"concepts":[{"id":"https://openalex.org/C2779931791","wikidata":"https://www.wikidata.org/wiki/Q161515","display_name":"DOTA","level":3,"score":0.8771717548370361},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.8721070885658264},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6463300585746765},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6269370913505554},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6130931377410889},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4710666537284851},{"id":"https://openalex.org/C197404232","wikidata":"https://www.wikidata.org/wiki/Q319827","display_name":"Chelation","level":2,"score":0.4701785147190094},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4463108777999878},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.4365115761756897},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3355453908443451},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3321557641029358},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.29562854766845703},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2316078245639801},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18086537718772888},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.17757746577262878},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16261622309684753},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000512","descriptor_name":"Alpha Particles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001729","descriptor_name":"Bismuth","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001729","descriptor_name":"Bismuth","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006571","descriptor_name":"Heterocyclic Compounds","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006571","descriptor_name":"Heterocyclic Compounds","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006573","descriptor_name":"Heterocyclic Compounds, 1-Ring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011868","descriptor_name":"Radioisotopes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011868","descriptor_name":"Radioisotopes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015375","descriptor_name":"Receptors, Interleukin-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:8242624","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8242624","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:1571370939","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8242624","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2173883894","https://openalex.org/W1978689317","https://openalex.org/W1841075178","https://openalex.org/W2442997519","https://openalex.org/W2015488412","https://openalex.org/W2055273899","https://openalex.org/W2112713404","https://openalex.org/W2102056877","https://openalex.org/W1972458654","https://openalex.org/W2093230307"],"abstract_inverted_index":{"A":[0],"major":[1],"factor":[2],"that":[3,20,78,100],"is":[4,14,79,99,114],"critical":[5],"to":[6,33,66,164,169,174,207,223,283],"the":[7,15,30,37,40,59,74,82,91,107,112,117,137,140,144,147,158,161,235,240,263,268,301,307,320,323,334],"potential":[8,335],"effectiveness":[9],"of":[10,17,36,50,54,94,119,139,146,160,209,231,257,270,277,289,296,306,313,322,333,337],"alpha-emitter":[11],"212Bi":[12,343],"radioimmunotherapy":[13,98,346],"design":[16],"radiometal-chelated":[18],"antibodies":[19],"will":[21],"be":[22],"stable":[23],"in":[24,97,126,131,182,183,192,239,259,327,347],"vivo.":[25],"The":[26,44,87,311],"chelate":[27],"should":[28],"bind":[29],"radiometal":[31,64],"firmly":[32],"minimize":[34],"release":[35,230],"radionuclide":[38],"from":[39,234,279,285],"monoclonal":[41,76,344],"antibody-chelate":[42,162],"complex.":[43,237],"present":[45],"study":[46],"examines":[47],"a":[48,51],"member":[49],"new":[52,339],"class":[53],"polyamine":[55],"carboxylate":[56],"chelating":[57,340],"compounds,":[58],"DOTA":[60,168,314],"ligands,":[61],"for":[62,90,342],"conjugating":[63],"ions":[65],"antibody.":[67,287],"Biocompatibility":[68],"and":[69,122,130,143,153,203,248,319],"stability":[70,321],"are":[71],"assessed":[72],"with":[73,198,213,217,316],"anti-Tac":[75],"antibody":[77,96,151,170,176,180,210,236,317,345],"directed":[80],"against":[81],"human":[83],"interleukin":[84,108],"2":[85,109],"receptors.":[86],"scientific":[88],"basis":[89],"clinical":[92],"use":[93],"this":[95,338],"resting":[101],"normal":[102],"cells":[103],"do":[104],"not":[105,178,211],"express":[106],"receptor,":[110],"whereas":[111],"receptor":[113],"expressed":[115],"on":[116,150],"surface":[118],"certain":[120],"neoplasms":[121],"by":[123,191],"activated":[124],"T-cells":[125],"select":[127],"autoimmune":[128],"diseases":[129],"allograft":[132],"rejection.":[133],"First,":[134],"we":[135,156],"examined":[136],"impact":[138],"labeling":[141],"procedure":[142],"presence":[145],"chelate,":[148],"DOTA,":[149],"bioavailability":[152],"survival.":[154],"Next,":[155],"studied":[157],"capacity":[159],"complex":[163,326],"retain":[165],"radiobismuth.":[166],"Coupling":[167],"or":[171],"adding":[172],"Bi(III)":[173],"DOTA-coupled":[175],"did":[177],"disturb":[179],"immunoreactivity":[181],"vitro":[184],"binding":[185],"studies.":[186],"In":[187],"addition,":[188],"as":[189],"analyzed":[190],"vivo":[193,328],"studies,":[194],"DOTA-antibody":[195],"dummy":[196],"labeled":[197],"nonradioactive":[199],"bismuth":[200,219,233,258,278,309,325],"showed":[201,220],"pharmacokinetics":[202,221],"tissue":[204],"distribution":[205],"identical":[206,222],"those":[208],"modified":[212],"DOTA.":[214],"DOTA-anti-Tac":[215],"charged":[216],"radioactive":[218,232,324],"radioiodinated":[224],"dummy-labeled":[225],"DOTA-antibody,":[226],"suggesting":[227],"little":[228],"premature":[229],"Moreover,":[238],"early,":[241],"therapeutically":[242],"relevant":[243],"time":[244,265],"points":[245],"(2":[246],"h":[247],"6":[249],"h),":[250],"there":[251,273],"was":[252,274],"no":[253],"significant":[254],"preferential":[255],"accumulation":[256,304],"any":[260],"organ.":[261],"At":[262],"5-day":[264],"point,":[266],"beyond":[267],"range":[269],"therapeutic":[271],"interest,":[272],"delayed":[275],"excretion":[276],"reticuloendothelial":[280],"tissues":[281],"relative":[282],"radioiodine":[284],"catabolized":[286,290],"Excretion":[288],"DOTA-bismuth":[291],"had":[292],"an":[293],"apparent":[294],"t1/2":[295],"approximately":[297],"1":[298],"day":[299],"without":[300],"marked":[302],"renal":[303],"typical":[305],"free":[308],"ion.":[310],"compatibility":[312],"conjugation":[315],"bioactivity":[318],"provide":[329],"important":[330],"preclinical":[331],"validation":[332],"utility":[336],"agent":[341],"humans.":[348]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}